K. Foe et al., Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma, J PHARM SCI, 89(9), 2000, pp. 1143-1150
The systemic availability of inhaled beclomethasone dipropionate (BDP) is t
he net result of the absorption of the glucocorticoid from the lower respir
atory and gastrointestinal tracts, and metabolism in the lung, plasma, and
other sites. The metabolism kinetics of BDP and its active metabolite, becl
omethasone 17-monopropionate (17-BMP), in human lung 1000 x g supernatant (
HLu) and human plasma (HP) at 37 degrees C were compared. The effect of MgC
l2 and/or an NADPH-generating system on the decomposition of BDP and 17-BMP
in HLu was also investigated. The concentrations of BDP and its metabolite
s were determined by HPLC with UV detection at 242 nm. Kinetics of decompos
ition of BDP and 17-BMP in HLu and HP were qualitatively and quantitatively
different. The decomposition of BDP in HLu involved only hydrolysis. In co
mparison, three reactions are involved following incubation of BDP in HP; n
amely, hydrolysis, transesterification, and loss of hydrogen chloride. The
hydrolysis of BDP and 17-BMP in HLu seem to be inhibited appreciably by MgC
l2 with the NADPH-generating system. Effective activation of BDP in HLu, in
combination with transesterification of 17-BMP in HP, might favor a high r
atio of local antiinflammatory activity to systemic side effects following
inhalation of BDP. (C) 2000 Wiley-Liss, Inc. and the American Pharmaceutica
l Association J Pharm Sci 89: 1143-1150, 2000.